Armistice Capital’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History
Bought
Maintained
Sold
Other funds holding PHXM
BI
CS
Armistice Capital's PHXM Position: Q2 2022 in Review
Armistice Capital sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q2 2022, closing a stake of 194,408 shares — an estimated $3.4M sold.
Armistice Capital first reported a position in PHXM in Q4 2021 and held it in 2 quarters. The position peaked at $6.43M in Q4 2021. 6 funds tracked by Wall St. Rank hold PHXM as of Q2 2022.
- Armistice Capital reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q2 2022 after selling out during the quarter.
- Armistice Capital sold 194,408 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q2 2022, an estimated $3.4M.
- Armistice Capital first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2021 and held it in 2 quarters.
- Armistice Capital's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $6.43M in Q4 2021.
- 6 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q2 2022.
Based on Armistice Capital's 13F filing for Q2 2022, filed 15 Aug 2022.